+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Female Contraceptive Market Research Report by Contraceptive Drug, by Contraceptive Devices, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4904506
  • Report
  • July 2021
  • Region: Global
  • 195 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Female Contraceptive Market will Grow to USD 11,213.43 Million by 2026, at a CAGR of 6.22%

FEATURED COMPANIES

  • Allergan plc
  • Bayer AG
  • Cipla Limited
  • HLL Lifecare Limited
  • Johnson & Johnson
  • Mankind Pharma
The Global Female Contraceptive Market size was estimated at USD 7,807.19 Million in 2020 and expected to reach USD 8,266.40 Million in 2021, at a Compound Annual Growth Rate (CAGR) 6.22% to reach USD 11,213.43 Million by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Female Contraceptive to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Contraceptive Drug, the Female Contraceptive Market was examined across Contraceptive Injections, Contraceptive Pills, Spermicides, and Topical Contraceptives. The Contraceptive Pills was further studied across Hormonal Pills and Non-hormonal Pills.
  • Based on Distribution Channel, the Female Contraceptive Market was examined across Clinic, Hospital Pharmacy, Independent Pharmacy, and Online Platform.
  • Based on Contraceptive Devices, the Female Contraceptive Market was examined across Contraceptive Patches, Contraceptive Sponges, Diaphragms and Caps, Female Condoms, Intra Uterine Contraceptive Devices (IUCDs), Sub-dermal Contraceptive Implants, and Vaginal Rings.
  • Based on Geography, the Female Contraceptive Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas was further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific was further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa was further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Female Contraceptive Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Female Contraceptive Market, including Allergan plc, Bayer AG, Cipla Limited, HLL Lifecare Limited, Johnson & Johnson, Mankind Pharma, Merck Sharp & Dohme Corp, Mithra Pharmaceuticals S.A., Pfizer Inc., and Reckitt Benckiser Group plc.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Female Contraceptive Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Female Contraceptive Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Female Contraceptive Market?
4. What is the competitive strategic window for opportunities in the Global Female Contraceptive Market?
5. What are the technology trends and regulatory frameworks in the Global Female Contraceptive Market?
6. What is the market share of the leading vendors in the Global Female Contraceptive Market?
7. What modes and strategic moves are considered suitable for entering the Global Female Contraceptive Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan plc
  • Bayer AG
  • Cipla Limited
  • HLL Lifecare Limited
  • Johnson & Johnson
  • Mankind Pharma
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Contraceptive Drug Outlook
3.4. Distribution Channel Outlook
3.5. Contraceptive Devices Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of unwanted pregnancies and sexually transmitted diseases
5.1.1.2. Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population
5.1.1.3. Multiple types and ease of availability of contraceptives
5.1.2. Restraints
5.1.2.1. Side effects of contraceptive drugs
5.1.3. Opportunities
5.1.3.1. Availability of contraceptives method such as Sino-Implants and novel contraceptive
5.1.3.2. Government and non-government organizations supporting programs to encourage contraception in emerging economies
5.1.4. Challenges
5.1.4.1. Social stigma and misconceptions about different contraceptives
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Female Contraceptive Market, by Contraceptive Drug
6.1. Introduction
6.2. Contraceptive Injections
6.3. Contraceptive Pills
6.3.1. Hormonal Pills
6.3.2. Non-hormonal Pills
6.4. Spermicides
6.5. Topical Contraceptives

7. Female Contraceptive Market, by Distribution Channel
7.1. Introduction
7.2. Clinic
7.3. Hospital Pharmacy
7.4. Independent Pharmacy
7.5. Online Platform

8. Female Contraceptive Market, by Contraceptive Devices
8.1. Introduction
8.2. Contraceptive Patches
8.3. Contraceptive Sponges
8.4. Diaphragms and Caps
8.5. Female Condoms
8.6. Intra Uterine Contraceptive Devices (IUCDs)
8.7. Sub-dermal Contraceptive Implants
8.8. Vaginal Rings

9. Americas Female Contraceptive Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Female Contraceptive Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Female Contraceptive Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Allergan plc
13.2. Bayer AG
13.3. Cipla Limited
13.4. HLL Lifecare Limited
13.5. Johnson & Johnson
13.6. Mankind Pharma
13.7. Merck Sharp & Dohme Corp
13.8. Mithra Pharmaceuticals S.A.
13.9. Pfizer Inc.
13.10. Reckitt Benckiser Group plc

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2020 (USD MILLION)
FIGURE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
FIGURE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2020 (USD MILLION)
FIGURE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2020 VS 2026 (%)
FIGURE 10. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2026
FIGURE 12. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 24. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
FIGURE 25. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
FIGURE 27. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2026 (USD MILLION)
FIGURE 30. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 31. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, 2018-2026 (USD MILLION)
FIGURE 32. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 33. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, 2018-2026 (USD MILLION)
FIGURE 34. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 35. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2020 VS 2026 (%)
FIGURE 36. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2020 VS 2026 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2026
FIGURE 38. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 42. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS AND CAPS, 2018-2026 (USD MILLION)
FIGURE 43. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS AND CAPS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 44. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, 2018-2026 (USD MILLION)
FIGURE 45. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 46. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES (IUCDS), 2018-2026 (USD MILLION)
FIGURE 47. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES (IUCDS), BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 48. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, 2018-2026 (USD MILLION)
FIGURE 49. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 50. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, 2018-2026 (USD MILLION)
FIGURE 51. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 52. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 53. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 55. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 56. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 57. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 58. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 59. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 60. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 61. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 63. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 64. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 65. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 66. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 67. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 68. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 69. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 70. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 71. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 72. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 74. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 75. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 76. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 77. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 78. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 79. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 80. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 81. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 82. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 83. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 84. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 85. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 86. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 87. GLOBAL FEMALE CONTRACEPTIVE MARKET: FPNV POSITIONING MATRIX
FIGURE 88. GLOBAL FEMALE CONTRACEPTIVE MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 89. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL FEMALE CONTRACEPTIVE MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL FEMALE CONTRACEPTIVE MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS AND CAPS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES (IUCDS), BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 23. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 24. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 25. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 26. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 27. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 28. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 29. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 30. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 31. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 32. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 33. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 34. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 35. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 36. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 37. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 38. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 39. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 40. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 41. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 42. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 43. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 44. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 45. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 46. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 47. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 48. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 49. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 50. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 51. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 52. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 53. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 54. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 55. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 56. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 57. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 58. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 59. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 60. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 61. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 62. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 63. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 64. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 65. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 66. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 67. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 68. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 69. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 70. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 71. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 72. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 73. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 74. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 75. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 76. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 77. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 82. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 83. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 84. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 85. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 86. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 87. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 88. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 89. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 90. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 91. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 92. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 93. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 94. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 95. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 96. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 97. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 98. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 99. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 100. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 101. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 102. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 103. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 104. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 105. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 106. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 107. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 108. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 109. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 110. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 111. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 112. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2026 (USD MILLION)
TABLE 113. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 114. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
TABLE 115. GLOBAL FEMALE CONTRACEPTIVE MARKET: SCORES
TABLE 116. GLOBAL FEMALE CONTRACEPTIVE MARKET: BUSINESS STRATEGY
TABLE 117. GLOBAL FEMALE CONTRACEPTIVE MARKET: PRODUCT SATISFACTION
TABLE 118. GLOBAL FEMALE CONTRACEPTIVE MARKET: RANKING
TABLE 119. GLOBAL FEMALE CONTRACEPTIVE MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 120. GLOBAL FEMALE CONTRACEPTIVE MARKET: MERGER & ACQUISITION
TABLE 121. GLOBAL FEMALE CONTRACEPTIVE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 122. GLOBAL FEMALE CONTRACEPTIVE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 123. GLOBAL FEMALE CONTRACEPTIVE MARKET: INVESTMENT & FUNDING
TABLE 124. GLOBAL FEMALE CONTRACEPTIVE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 125. GLOBAL FEMALE CONTRACEPTIVE MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Allergan plc
  • Bayer AG
  • Cipla Limited
  • HLL Lifecare Limited
  • Johnson & Johnson
  • Mankind Pharma
  • Merck Sharp & Dohme Corp
  • Mithra Pharmaceuticals S.A.
  • Pfizer Inc.
  • Reckitt Benckiser Group plc
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll